Literature DB >> 5695310

Aminophylli Oral vs rectal administration.

J P Lillehei.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5695310     DOI: 10.1001/jama.205.7.530

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  8 in total

Review 1.  Clinical pharmacokinetics of theophylline.

Authors:  R I Ogilvie
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

Review 2.  Monitoring serum theophylline levels.

Authors:  L Hendeles; M Weinberger; G Johnson
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

3.  Plasma theophylline level and effect on lung function after oral and rectal administration of aminophylline.

Authors:  H Lamont; E Moerman; M Bogaert; M Van Der Straeten; R Pauwels
Journal:  Eur J Clin Pharmacol       Date:  1979-07       Impact factor: 2.953

Review 4.  Rectal drug administration: clinical pharmacokinetic considerations.

Authors:  A G de Boer; F Moolenaar; L G de Leede; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1982 Jul-Aug       Impact factor: 6.447

5.  Pharmacokinetics of theophylline in young children with asthma: comparison of rectal enema and suppositories.

Authors:  P Bolme; P O Edlund; M Eriksson; L Paalzow; B Winbladh
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

6.  Serum theophylline levels after use of an anhydrous crystalline theophylline suppository.

Authors:  J Aarbakke; A Høylandskjaer; O N Gamst
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

7.  Oral sustained-release aminophylline in medical inpatients: factors related to toxicity and plasma theophylline concentrations.

Authors:  L E Ramsay; A Mackay; M L Eppel; J S Oliver
Journal:  Br J Clin Pharmacol       Date:  1980-08       Impact factor: 4.335

8.  Disposition and clinical pharmacokinetics of microcrystalline theophylline.

Authors:  J H Jonkman; W C Berg; R Schoenmaker; R A de Zeeuw; J E Greving; N G Orie
Journal:  Eur J Clin Pharmacol       Date:  1980-05       Impact factor: 2.953

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.